Literature DB >> 35102514

Migraine and the risk of dementia: a meta-analysis and systematic review.

Wei Jiang1, Guo-Hua Liang2, Jia-Ai Li1, Peng Yu3, Ming Dong4.   

Abstract

OBJECTIVES: To conduct a comprehensive systematic review and meta-analysis to explore the correlation between migraine and the risk of dementia.
METHODS: The PubMed, EMBASE, and Cochrane library databases were searched systematically. We selected cohort studies (prospective and retrospective) and case-control studies that reported migraine in patients with dementia, including vascular dementia. The pooled effects were analyzed to evaluate relative risk with 95% confidence intervals.
RESULTS: In total, nine studies (two case-control and seven cohort studies) including 291,549 individuals were identified. These studies indicated that people with migraine (relative risk = 1.33; 95% confidence interval: 1.16-1.53) have an increased risk of all-cause dementia. Additionally, the pooled results of four studies showed that migraine is associated with an increased risk of vascular dementia (relative risk = 1.85; 95% confidence interval: 1.22-2.81; P = 0.004).
CONCLUSIONS: Data from observational studies suggest that migraine may be a risk factor for dementia, particularly vascular dementia. More studies are warranted to explore the association between migraine and dementia and the potential common pathophysiological mechanisms.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Alzheimer’s disease; Dementia; Meta-analysis; Migraine; Vascular dementia

Mesh:

Year:  2022        PMID: 35102514     DOI: 10.1007/s40520-021-02065-w

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  45 in total

Review 1.  The impact of migraine and the effect of migraine treatment on workplace productivity in the United States and suggestions for future research.

Authors:  Wayne N Burton; Stephen H Landy; Kristen E Downs; M Chris Runken
Journal:  Mayo Clin Proc       Date:  2009-05       Impact factor: 7.616

Review 2.  Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective.

Authors:  Matthew Baumgart; Heather M Snyder; Maria C Carrillo; Sam Fazio; Hye Kim; Harry Johns
Journal:  Alzheimers Dement       Date:  2015-06-01       Impact factor: 21.566

3.  Direct and Indirect Costs Among United States Commercially Insured Employees With Migraine.

Authors:  Adrienne M Gilligan; Shonda A Foster; Amy Sainski-Nguyen; Robert Sedgley; David Smith; Paula Morrow
Journal:  J Occup Environ Med       Date:  2018-12       Impact factor: 2.162

Review 4.  Dementia.

Authors:  Seth A Gale; Diler Acar; Kirk R Daffner
Journal:  Am J Med       Date:  2018-02-06       Impact factor: 4.965

5.  Migraine prevalence, disease burden, and the need for preventive therapy.

Authors:  R B Lipton; M E Bigal; M Diamond; F Freitag; M L Reed; W F Stewart
Journal:  Neurology       Date:  2007-01-30       Impact factor: 9.910

Review 6.  Migraine.

Authors:  Stephen D Silberstein
Journal:  Lancet       Date:  2004-01-31       Impact factor: 79.321

7.  Alzheimer disease in the United States (2010-2050) estimated using the 2010 census.

Authors:  Liesi E Hebert; Jennifer Weuve; Paul A Scherr; Denis A Evans
Journal:  Neurology       Date:  2013-02-06       Impact factor: 9.910

8.  Migraine and risk of dementia: a nationwide retrospective cohort study.

Authors:  Chieh-Sen Chuang; Cheng-Li Lin; Ming-Chia Lin; Fung-Chang Sung; Chia-Hung Kao
Journal:  Neuroepidemiology       Date:  2013-07-30       Impact factor: 3.282

9.  The incidence of dementia: a meta-analysis.

Authors:  A F Jorm; D Jolley
Journal:  Neurology       Date:  1998-09       Impact factor: 9.910

Review 10.  Dementia prevention, intervention, and care.

Authors:  Gill Livingston; Andrew Sommerlad; Vasiliki Orgeta; Sergi G Costafreda; Jonathan Huntley; David Ames; Clive Ballard; Sube Banerjee; Alistair Burns; Jiska Cohen-Mansfield; Claudia Cooper; Nick Fox; Laura N Gitlin; Robert Howard; Helen C Kales; Eric B Larson; Karen Ritchie; Kenneth Rockwood; Elizabeth L Sampson; Quincy Samus; Lon S Schneider; Geir Selbæk; Linda Teri; Naaheed Mukadam
Journal:  Lancet       Date:  2017-07-20       Impact factor: 202.731

View more
  3 in total

1.  The mysterious connection between migraine and dementia: epiphenomenon or causation? Special considerations.

Authors:  Lavinia Vassallo; Antonino Lupica; Vincenzo Di Stefano; Roberto Monastero; Filippo Brighina
Journal:  Aging Clin Exp Res       Date:  2022-06-24       Impact factor: 4.481

2.  Preventive treatment can reverse cognitive impairment in chronic migraine.

Authors:  Cristina González-Mingot; Anna Gil-Sánchez; Marc Canudes-Solans; Silvia Peralta-Moncusi; Maria José Solana-Moga; Luis Brieva-Ruiz
Journal:  J Headache Pain       Date:  2022-09-15       Impact factor: 8.588

Review 3.  Migraine Pharmacological Treatment and Cognitive Impairment: Risks and Benefits.

Authors:  Mirella Russo; Matteo A De Rosa; Dario Calisi; Stefano Consoli; Giacomo Evangelista; Fedele Dono; Matteo Santilli; Alberto Granzotto; Marco Onofrj; Stefano L Sensi
Journal:  Int J Mol Sci       Date:  2022-09-27       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.